igf-1 des vs igf-1 lr3 LR3, DES(1-3) IGF-1, and PEG-MGF: Analogue Cluster IGF-1 LR3 1MG Research Peptide
Description
Two ongoing phase I, randomized, double-blind, placebo-controlled trials are ongoing and aim to evaluate safety, tolerability and target engagement of DNL151 in healthy volunteers (NCT04557800) and PD patients (NCT04056689)
Construction of LRET-based nanoprobe using upconversion nanoparticles with confined emitters and bared surface as luminophore
The exogen phase is essentially an extension of the telogen stage of hair growth
5-Oxoprolinuria due to glutathione synthetase deficiency
